Long Island City, NY, United States of America

Tyler D Ames

USPTO Granted Patents = 3 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Long Island City, NY (US) (2020 - 2021)
  • Brooklyn, NY (US) (2022)

Company Filing History:


Years Active: 2020-2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Tyler D. Ames

Introduction

Tyler D. Ames, a distinguished inventor based in Long Island City, NY, has made significant contributions to the field of cancer treatment through his innovative approaches and research. With a total of three patents to his name, he focuses on the development of novel pharmaceutical compounds that aim to enhance immunotherapy in oncology.

Latest Patents

Among his latest patents is the groundbreaking work on "Phosphaplatin compounds as immuno-modulatory agents and therapeutic uses thereof." This patent details the use of (pyrophosphato)platinum(II) and platinum(IV) complexes, specifically 1,2-cyclohexanediamine(pyrophosphato) platinum(II), which serve as immunogenic cell death (ICD) inducing agents. The patent explores their combination with immune checkpoint protein inhibitors for the treatment of various cancers, alongside the mechanistic rationale for these methods.

In addition, Tyler D. Ames holds a patent for "Phosphaplatin liquid formulations." This patent discloses pharmaceutical compositions of phosphaplatin compounds, particularly buffered stable liquid formulations of pyrodach-2, designed for ease of use in treating different cancer types, along with their methods of preparation.

Career Highlights

Tyler’s work primarily revolves around his role at Phosplatin Therapeutics Inc., where he actively participates in advancing therapeutic applications of phosphaplatin compounds. His dedication to cancer research and innovation has solidified his reputation as a valuable contributor in the field of oncology.

Collaborations

Throughout his career, Tyler D. Ames has collaborated with notable colleagues, including Matthew Price and Wayne Douglas Luke. These partnerships enhance the research environment and foster creativity, leading to the successful development of novel cancer therapies.

Conclusion

Tyler D. Ames continues to be an influential figure in the realm of cancer treatment innovations. His work on phosphaplatin compounds showcases the potential of innovative pharmacological approaches in combating cancer, promising a brighter future for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…